New Weight Loss Drug Retatrutide Shows ‘Stunning’ Results in Phase 3 Trial
A new investigational weekly injection called retatrutide helped adults with obesity and type 2 diabetes lose nearly a fifth of their starting weight in a major phase 3 clinical trial.